Phase I/II Trial of Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies
Conditions:   Cervical Cancer;   HPV Cancers;   Anal Cancer;   Oropharyngeal Cancer;   Vulvar, Vaginal, Penile, Rectal Cancer Interventions:   Biological: PDS0101;   Biological: M7824;   Biological: NHS-IL12 Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2020 Category: Research Source Type: clinical trials

Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies
Conditions:   Cervical Cancer;   HPV Cancers;   Anal Cancer;   Oropharyngeal Cancer;   Vulvar, Vaginal, Penile, Rectal Cancer Interventions:   Biological: PDS0101;   Biological: M7824;   Biological: NHS-IL12 Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2020 Category: Research Source Type: clinical trials